A patient with a chronic, large fibre sensory neuropathy had an immunoglobulin MB monoclonal paraprotein reactive at titres in excess of 1/105 with NeuNAc(a2-8)NeuNAc(a2-3)Gal configured disialosyl groups present on the gangliosides GDlb, GTlb, GQlb, and GD3. The paraprotein showed weaker reactivity with GDla, GM3, and LM1 but no reactivity with GM2, GM1, or asialo-GM1. In addition, the paraprotein had cold agglutinating activity with anti-Pr2 specificity, Pr2 being an antigenic determinant on membrane glycoproteins or glycolipids in erythrocytes or both. A large fibre sensory neuropathy with monoclonal anti-disialosyl antibodies is an increasingly recognised form of paraproteinaemic neuropathy.
Many recent studies have focused on peripheral neuropathy syndromes associated with immunoglobulin (IgM) paraproteinaemia. 1 The specificity of the paraproteins is almost invariably directed to carbohydrate determinants present on different glycoproteins and glycolipids distributed in neural tissue. 2 Recognised clinical and serological associations include (a) a chronic demyelinating sensorimotor neuropathy associated with the paraprotein directed against a sulphated glucuronic acid epitope shared by sulphated glucuronyl paragloboside, myelin-associated glycoprotein and the myelin P0 protein,' and (b) a multifocal motor neuropathy with the paraprotein directed against GM1 ganglioside and related glycoconjugates containing a terminal Gal(fil-3)GalNAc configuration.' Although well described, these associations are not absolute or exclusive in that substantial overlap exists between the clinical and serological features of these patients. 4 Among patients with paraproteinaemic neuropathy in general, there may yet be other clinical and serological associations that remain to be identified. In this report we describe a patient with a large fibre neuropathy with prominent sensory symptoms and ataxia, and clinically absent motor involvement in whom an IgM On examination she had an area of perioral sensory loss to pinprick but otherwise normal cranial nerves. In the limbs, there was no wasting or weakness. She was areflexic. Glove and stocking sensory loss to light touch and pinprick was present with an additional area of sensory loss over the mid-abdominal region and sternum. Joint position sense was markedly impaired in the digits, and vibration sense absent to the elbows and ribs. Deep pain and thermal sensation was normal. She had prominent pseudoathetosis of the outstretched hands and gait ataxia with a positive Romberg test.
Electrophysiological examination (kindly performed by Dr G Jamal) of motor nerves revealed prolonged distal motor latencies and F wave latencies (right common peroneal latency: 6-9 ms, F wave: 76-4 ms; right tibial latency: 5-8 ms, F wave: 83-9 ms; right median latency: 5-2 ms, F wave: 43-2 ms). Motor conduction velocities in the leg and arm were reduced (right common peroneal: 34 m/s; right tibial: 30 GQlb. Wells were filled with 200 p1 PBS-BSA (pH 7-4, 3% bovine serum albumin) and left for two hours at 4°C, emptied, and 100 pul of serially diluted test serum in PBS-0-1% BSA was added in duplicate to glycolipid coated and to blank wells which had been soaked in methanol and blocked in the same way. The plate was left to incubate with serum overnight at 4°C, washed 10 times in PBS, and 100 pul of a 1/3000 dilution of peroxidase-conjugated rabbit anti-human IgM or IgG (Dako) or a 1/2000 dilution of antihuman K or A light chain antibody (Sigma) was added. The plate was incubated for a further four hours at 4°C, washed 10 times in PBS and the plate developed by adding substrate solution consisting of one 20 mg ophenylenediamine tablet (Sigma) in 60 ml 0O1M citrate buffer pH5-5 with 20 pl of 30% hydrogen peroxide. The reaction was stopped with 20 pl of 4M sulphuric acid after 20 minutes and the optical densities read in an MR5000 plate-reader (Dynatech). Antibody titres were calculated by subtracting the optical densities of the blank well from those of the ganglioside-coated well and plotting the resultant optical density versus the dilution on semi-log paper. The dilution at which the baseline optical density (defined as three standard deviations above that obtained with second antibody alone) was crossed was assigned as the antibody titre.
THIN LAYER CHROMATOGRAPHY (TLC)

OVERLAY
Gangliosides were separated on aluminium backed Kieselgel 60 WF,54 S HPTLC plates (Merck) in the solvent system chloroform:methanol:0 25% potassium chloride in a volume ratio of 50:40:10. An aliquot of a standard ganglioside mixture containing LM1 was kindly provided by Dr D Marcus, Baylor College, Houston, Texas, United States. The chromatograms were air-dried, dipped in 0O1% polyisobutylmethacrylate beads for 20 s at 40°C, air dried, blocked with 1% BSA in PBS pH 7-5 for one hour, incubated with the test serum in appropriate dilutions in blocking buffer for four hours at 4°C, washed five times in blocking buffer, incubated for 2-3 hours at 4°C with peroxidase-conjugated rabbit anti-human IgM diluted 1/3000 (Dako) and washed five times in blocking buffer. Plates were developed autoradiographically for 5-30 s using an enhanced chemiluminescence procedure according to manufacturer's instructions (Amersham, United Kingdom).
IMMUNOABSORPTION AND PURIFICATION STUDIES
Cold agglutinating antibodies were purified from normal human red blood cells as follows: group 0 red blood cells were washed four times in PBS (001M, pH 7.4). One volume of packed cells was then incubated with one volume of plasma at 4°C with occasional mixing for one hour. This produced an aggregated pellet which was centrifuged at 4°C (five minutes, 2500 rpm) and washed six times in ice cold PBS with mechanical deagglutination at each wash. Following the last centrifugation, the wash supernatant was removed and replaced by one volume of PBS and the cells were gently mixed at 40°C for five minutes. This mixture was centrifuged immediately (in buckets containing water at 40°C) and the supernatant, which contained a fine milky precipitate was transferred to a clean tube. This material is referred to as RBC-IgM. Immunoabsorption studies were also carried out by pre-incubation of appropriate dilutions of RBC-IgM with enzymelinked immunosorbent assay (ELISA) plates demonstrated determinant. ELISA assays using K and A light chain specific antibodies showed the reactivity to these gangliosides to be in the A light chain fraction, consistent with the typing of the patient's serum paraprotein as IgMA. There were no IgG anti-ganglioside antibodies.
The red blood cell purified IgM fraction (RBC-IgM) focused in IEF gels as a single paraprotein at the same isoelectric point as the paraprotein present in the serum and also exhibited the same heavy and light chain type (IgMA) as the serum paraprotein (data not shown). In ELISA (fig 1) and TLC (fig 2) studies, the RBC-IgM reacted with GDlb, The reactivity of anti-Pr2 monoclonal IgM antibodies with gangliosides has been recognised for many years, and in human erythrocytes the Pr, determinants are carried by sialylated glycoproteins.1920 Although clearly similar, many of these anti-Pr2 antibodies differ very slightly in fine specificity from each other. For example, the anti-Pr2 antibody described by Uemura et al2" had a higher affinity for the monosialosyl structure NeuNAc(a2-3)Gal(#l-4)Glc-or NeuNAc (a2-3)-Gal(ffl-4)GlcNAc-(present, for example, on GM3, GDla, and LM1) compared with the disialosyl structure NeuNAc(a2-8)NeuNAc(a2-3)Gal-(present, for example on GDlb, GTlb and GD3). In contrast, the anti-Pr2 antibodies described by us, Arai et al 9 and Obi et al 10 react more strongly with the disialosyl structure NeuNAc(a2-8)NeuNAc(a2-3)Gal-than the monosialosyl structure NeuNAc(a2-3)-Gal(fl-4)Glc-. Thus the paraproteins among the neuropathy patients tend to have preference for the disialosyl structure as the dominant reactive determinant (see table 2 ). Whether these preferences can be related to antibody binding to putative target antigens in vivo is unknown.
The composition of gangliosides in central and peripheral nervous tissue varies greatly between species. Whole human peripheral nerve and peripheral nerve myelin contain GDlb and GTlb," which react with our paraprotein and the monoclonal antibody A2B5.6 In addition, LM1 is a major peripheral nerve ganglioside23 which also reacts with our paraprotein, albeit less strongly than with the disialosyl gangliosides. Human nerve thus has target antigens for anti-disialosyl antibodies. It is therefore surprising that no immunoglobulin deposits were noted in the sural nerve biopsy of our case or the other four similar cases that have been described, despite the fact that extensive pathology was evident in the biopsies. Human Which of these will turn out to be the case awaits further investigation.
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